Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: A single institution result of 168 patients

Leukemia and Lymphoma

Volumn 49, Issue 4, 2008, Pages 769-778

  Akhtar, Saad ^a   Weshi, Amr El ^a   Rahal, Mohemmed ^a   Khafaga, Yasser ^a   Tbakhi, Abdelghani ^a   Humaidan, Hind ^a   Maghfoor, Irfan ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

CD34+ cells; ESHAP; G CSF; Hodgkin lymphoma; Non hodgkin lymphoma; Stem cell mobilisation

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE;

ADULT; AGE; APHERESIS; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BODY WEIGHT; BONE MARROW DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CD34 SELECTION; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; GENDER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALVAGE THERAPY; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; TREATMENT FAILURE;

ADULT; AGE FACTORS; ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; PLATELET COUNT; RECURRENCE; SALVAGE THERAPY; SEX FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 42049120992     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701843213     Document Type: Conference Paper

References (30)

1. Dazzi, C., Cariello, A., Rosti, G., Argnani, M., Sebastiani, L. and Ferrari, E. (2000) Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's Lymphoma?. Leuk Lymphoma, 39, pp. 301-310.
2. Deliliers, G. L., Annaloro, C., Marconi, M., Soligo, D., Morandi, P. and Luchesini, C. (2002) Harvesting of autologous blood stem cells after a mobilising regimen with low-dose cyclophosphamide. Leuk Lymphoma, 43, pp. 1957-1960.
3. Kotasek, D., Shepherd, K. M., Sage, R. E., Dale, B. M., Norman, J. E. and Charles, P. (1992) Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant, 9, pp. 11-17.
4. McQuaker, I. G., Haynes, A. P., Stainer, C., Anderson, S. and Russell, N. H. (1997) Stem cell mobilization in resistant or relapsed lymphoma. Superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol, 98, pp. 228-233.
5. Morton, J., Morton, A., Bird, R., Hutchins, C. and Durrant, S. (1997) Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF. Leukemia Res, 21, pp. 21-27.
6. Pavone, V., Gaudio, F., Guarini, A., Perrone, T., Zonno, A. and Curci, P. (2002) Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma. Bone Marrow Transplant, 29, pp. 285-290.
7. Shepherd, K. M., Charles, P., Sage, R. E., Dale, B. M., Norman, J. E. and Kotasek, D. (1991) Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin Lab Haematol, 13, pp. 25-32.
8. Watts, M. J., Sullivan, A. M., Jamieson, E., Pearce, R., Fielding, A. and Devereux, S. (1997) Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: An analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. J Clin Oncol, 15, pp. 535-546.
9. Magagnoli, M., Sarina, B. and Balzarotti, M. (2001) Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma. Bone Marrow Transplant, 28, pp. 923-927.
10. Petit, J., Boqué, C., Cancelas, J. A., Sarrà, J., Muñoz, J. and Garcia, J. (1999) Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: A single-center study of 22 patients. Leuk Lymphoma, 34, pp. 119-127.
11. Watts, M. J., Ings, S. J. and Leverett, D. (2000) ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: A matched pairs analysis of 78 patients. Br J Cancer, 82, pp. 278-282.
12. Zinzani, P. L., Tani, M., Molinari, A. L., Stefoni, V., Zuffa, E. and Alinari, L. (2002) Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients. Haematologica, 87, pp. 816-821.
13. Lee, J. L., Kim, S., Kim, S WKE, Kim, S. B., Kang, Y. K. and Lee, J. (2005) ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: Comparison with high-dose cyclophosphamide plus G-CSF. Bone Marrow Transplantation, 35, pp. 449-454.
14. Velasquez, W. S., McLaughlin, P., Tucker, S., Hagemeister, F. B., Swan, F. and Rodriguez, M. A. (1994) E-SHAP an effective chemotherapy in refractory and relapsing lymphoma: A 4-year follow-up. J Clin Oncol, 6, pp. 1169-1176.
15. Akhtar, S., Tbakhi, A., Humaidan, H., Weshi, A El, Rahal, M. and Maghfoor, I. (2006) ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: A single institution result of 127 patients. Bone Marrow Transplantation, 37, pp. 277-282.
16. Brocklebank, A. M. and Sparrow, R. L. (2001) Enumeration of CD341 Cells in Cord Blood: A variation on a single-platform flow cytometric method based on the ISHAGE gating strategy. Cytometry (Comm Clin Cytometry), 46, pp. 254-261.
17. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J. and Lilleby, K. (1995) Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol, 13, pp. 2547-2555.
18. Clark, R. E. and Brammer, C. G. (1998) Previous treatment predicts the efficiency of blood progenitor cell mobilization: Validation of a chemotherapy scoring system. Bone Marrow Transplant, 22, pp. 859-863.
19. Drake, M., Ranaghan, L., Morris, T. C., Nolan, L., Desai, Z. R. and Irvine, A. E. (1997) Analysis of the effect of prior therapy on progenitor cell yield: Use of a chemotherapy scoring system. Br J Haematol, 98, pp. 745-749.
20. Ford, C. D., Chan, K., Reilly, W. F. and Petersen, F. B. (2003) An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion, 43, pp. 622-625.
21. Micallef, I. N., Apostolidis, J., Rohatiner, A. Z., Wiggins, C., Crawley, C. R. and Foran, J. M. (2000) Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. Hematol J, 1, pp. 367-373.
22. Kuittinen, T., Nousiainen, T., Halonen, P., Mahlamäki, E. and Jantunen, E. (2004) Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant, 33, pp. 907-912.
23. Ford, C. D., Green, W., Warenski, S. and Petersen, F. B. (2004) Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant, 33, pp. 901-905.
24. Koumakis, G., Vassilomanolakis, M., Hatzichristou, H., Barbounis, V., Filis, J. and Papanastasiou, K. (1996) Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD, CHE) in various malignancies. Bone Marrow Transplant, 18, pp. 1065-1072.
25. Canales, M. A., Fernandez-Jimenez, M. C., Martin, A., Arrieta, R., Caballero, M. D. and Diez, J. (2001) Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica, 86, pp. 494-498.
26. Lee, J. L., Kim, S. B., Lee, G. W., Ryu, M. H., Kim, E. K. and Kim, S. (2003) Collection of peripheral blood progenitor cells: Analysis of factors predicting the yields. Transfus Apheresis Sci, 29, pp. 29-37.
27. Ketterer, N., Salles, G., Moullet, I., Dumontet, C., ElJaafari-Corbin, A. and Tremisi, P. (1998) Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol, 103, pp. 235-242.
28. Morton, J. A., Baker, D. P., Hutchins, C. J. and Durrant, S. T. (1997) The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim. Transfusion, 37, pp. 631-633.
29. Jeanne, M., Bouzgarrou, R., Lafarge, X., Fizet, D., Dazey, B. and Vezon, G. (2003) Comparison of CD34+ cell collection on the CS-3000+ and Amicus blood cell separators. Transfusion, 43, pp. 1423-1427.
30. Kessinger, A. and Sharp, J. G. (2003) The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplant, 31, pp. 319-329.